EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Triple Antithrombotic Therapy vs Dual Antiplatelet for Prevention of Left Ventricular Thrombus After Anterior Myocardial Infarction: An Updated Meta-Analysis

Mustafa Abomohsen, Ibrahim Elkhayat iD, Ahmed Elmorsy Mohamed, Abdul Hakim Almakadma, Zeyad Kholeif, Ahmed Farid Gadelmawla iD, Ameer Awashra iD, Muhammed A Youssef, Osamah AlQassab, Mohamed Ghannam, Vikas Patel, Azad Mojahedi und 4 weitere

Clinical and Applied Thrombosis/Hemostasis · 2026-01 · 32

DOI: 10.1177/10760296261468426 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, online erschienen am 10.07.2026. Verfasst von Mustafa Abomohsen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Brookdale University Hospital & Medical Center, Brooklyn, NY, USA. Hauptthemen laut MEDLINE: Thrombosis, Platelet Aggregation Inhibitors, Fibrinolytic Agents, Heart Ventricles. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the efficacy and safety of triple antithrombotic therapy (TT) versus dual antiplatelet therapy (DAPT) for prevention of left ventricular thrombus (LVT) following anterior myocardial infarction.

Methods

We conducted a systematic review and meta-analysis of randomized and observational studies comparing TT (DAPT plus anticoagulation) versus DAPT alone. The primary outcome was LVT formation. Secondary outcomes included all-cause mortality, stroke, systemic embolism, composite thromboembolism, bleeding, and net adverse clinical events (NACE). Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models. The protocol was registered in PROSPERO (CRD420261343867).

Results

Seven studies (2 randomized, 5 observational), including 2,273 patients (949 TT, 1,324 DAPT), were analyzed. TT was not associated with a reduction in LVT (OR 0.56, 95% CI 0.21–1.49; p=0.25; I 2 =59%). There was no significant difference in all-cause mortality (OR 0.75, 95% CI 0.27–2.06; p=0.58), ischemic cerebrovascular accidents (OR 1.17, 95% CI 0.20–6.79), systemic embolism (OR 0.69, 95% CI 0.27–1.75), or composite thromboembolism (OR 0.96, 95% CI 0.42–2.19). TT was associated with increased major bleeding (OR 2.82, 95% CI 1.40–5.68; p=0.004) and any bleeding (OR 2.58, 95% CI 1.73–3.85; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombosisPlatelet Aggregation InhibitorsFibrinolytic AgentsHeart VentriclesMyocardial InfarctionAnterior Wall Myocardial InfarctionHumansFemaleMale

Stichwörter der Autor:innen

acute coronary syndromedual antiplatelet therapyleft ventricular thrombustriple antithrombotic therapy

Substanzen

Platelet Aggregation InhibitorsFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Brookdale University Hospital & Medical Center, Brooklyn, NY, USA.
  • Department of Cardiology, El Zaitoun Specialized Hospital, Cairo, Egypt.
  • Department of Internal Medicine, Baptist Hospital of Southeast Texas, Beaumont, TX, USA.
  • Faculty of Medicine, Menoufia University, Menoufia, Egypt.
  • Department of Internal Medicine, An-Najah University, Nablus, Palestine.
  • Department of Cardiology, October 6th University, Giza, Egypt.

ORCID-Profile: Ibrahim Elkhayat, Ahmed Farid Gadelmawla, Ameer Awashra

Zitieren

APA

Abomohsen, M., Elkhayat, I., Mohamed, A. E., Almakadma, A. H., Kholeif, Z., Gadelmawla, A. F., Awashra, A., Youssef, M. A., AlQassab, O., Ghannam, M., Patel, V., Mojahedi, A., Idries, I., Farid, M., Gunsburg, M., & Chadow, H. L. (2026). Triple Antithrombotic Therapy vs Dual Antiplatelet for Prevention of Left Ventricular Thrombus After Anterior Myocardial Infarction: An Updated Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis, 32. https://doi.org/10.1177/10760296261468426

Vancouver

Abomohsen M, Elkhayat I, Mohamed AE, Almakadma AH, Kholeif Z, Gadelmawla AF, et al. Triple Antithrombotic Therapy vs Dual Antiplatelet for Prevention of Left Ventricular Thrombus After Anterior Myocardial Infarction: An Updated Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis. 2026;32. doi:10.1177/10760296261468426

BibTeX
@article{Abomohsen2026,
  author = {Abomohsen, Mustafa and Elkhayat, Ibrahim and Mohamed, Ahmed Elmorsy and Almakadma, Abdul Hakim and Kholeif, Zeyad and Gadelmawla, Ahmed Farid and Awashra, Ameer and Youssef, Muhammed A and AlQassab, Osamah and Ghannam, Mohamed and Patel, Vikas and Mojahedi, Azad and Idries, Iyad and Farid, Meena and Gunsburg, Moshe and Chadow, Hal L},
  title = {Triple Antithrombotic Therapy vs Dual Antiplatelet for Prevention of Left Ventricular Thrombus After Anterior Myocardial Infarction: An Updated Meta-Analysis},
  journal = {Clinical and Applied Thrombosis/Hemostasis},
  year = {2026},
  volume = {32},
  doi = {10.1177/10760296261468426}
}
Kostenlos starten →